Endothelial microparticles (EMPs) act as early biomarkers of endothelial activation and damage. No studies have investigated EMPs in preterm-born individuals.
Sixty-three preterm-born children and 52 children born full-term (controls) were studied. Circulating CD62E(+), CD144(+), and CD31(+)/CD42b(−) EMPs were measured in preterm-born children compared to controls; possible associations with cardiovascular risk factors and endothelial function parameters were also assessed.
Circulating CD62E(+), CD144(+), and CD31(+)/CD42b(−) EMPs were significantly higher in preterm-born children compared to controls (p = 0.003, p < 0.001, and p < 0.001, respectively). Preterm birth was recognized as an independent predictor of each EMP subpopulation studied; moreover, the mean pressure and velocity of pulmonary artery were independently correlated with CD62E(+) (β = 0.20, p = 0.04) and CD144(+) EMPs (β = 0.22, p = 0.02), respectively, whereas age (β = 0.21, p = 0.03) and being born SGA (β = 0.26, p = 0.01) correlated independently with CD31(+)/CD42b(−) EMPs in the study population. Furthermore, diastolic blood pressure (β = 0.24, p = 0.04), being born SGA (β = 0.24, p = 0.04) and the hyperemic peak velocity of the brachial artery (β = −0.65, p = 0.02) were independently associated with CD31(+)/CD42b(−) EMPs in the preterm-born group.
Circulating EMPs were higher in preterm-born children compared to children born full-term. Whether EMPs could act, in clinical practice, as a complementary tool for non-invasive evaluation of endothelium in preterm-born children, remains under investigation.
Circulating endothelial microparticles (EMPs) are small membrane vesicles released from endothelial cells and they act as novel biomarkers of endothelial activation and damage.
No studies have investigated circulating EMPs in preterm-born individuals.
Circulating EMPs were significantly higher in prepubertal preterm-born children compared to children born at term.
In the preterm-born group, the hyperemic peak velocity of the brachial artery was independently associated with CD31(+)/CD42b(−) EMPs.
Whether assessment of circulating EMPs could act, in clinical practice, as a complementary tool for non-invasive evaluation of endothelium in preterm-born children, remains to be defined in future investigations.
Subscribe to Journal
Get full journal access for 1 year
only $9.15 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Heindel, J. J. et al. Developmental origins of health and disease: integrating environmental influences. Endocrinology 156, 3416–3421 (2015).
Bavineni, M. et al. Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood. Eur. Heart J. 40, 1107–1112 (2019).
Bassareo, P. P., Namana, V., Fanos, V. & Mercuro, G. Preterm birth and risk of heart failure up to early adulthood. J. Am. Coll. Cardiol. 70, 1943–1944 (2017).
Carr, H., Cnattingius, S., Granath, F., Ludvigsson, J. F. & Edstedt Bonamy, A. K. Preterm birth and risk of heart failure up to early adulthood. J. Am. Coll. Cardiol. 69, 2634–2642 (2017).
Crump, C. et al. Association of preterm birth with risk of ischemic heart disease in adulthood. JAMA Pediatr. 179, 736–743 (2019).
Markopoulou, P., Papanikolaou, E., Analytis, A., Zoumakis, E. & Siahanidou, T. Preterm birth as a risk factor for metabolic syndrome and cardiovascular disease in adult life: a systematic review and meta-analysis. J. Pediatr. 210, 69–80 (2019).
de Jong, F., Monuteaux, M. C., van Elburg, R. M., Gillman, M. W. & Belfort, M. B. Systematic review and meta-analysis of preterm birth and later systolic blood pressure. Hypertension 59, 226–234 (2012).
Kajantie, E. et al. Insulin sensitivity and secretory response in adults born preterm: the Helsinki Study of Very Low Birth Weight Adults. J. Clin. Endocrinol. Metab. 100, 244–250 (2015).
Sipola-Leppänen, M. et al. Cardiometabolic risk factors in young adults who were born preterm. Am. J. Epidemiol. 181, 861–873 (2015).
Breukhoven, P. E., Kerkhof, G. F., Willemsen, R. H. & Hokken-Koelega, A. C. Fat mass and lipid profile in young adults born preterm. J. Clin. Endocrinol. Metab. 97, 1294–1302 (2012).
Hovi, P. et al. Intima-media thickness and flow-mediated dilatation in the Helsinki study of very low birth weight adults. Pediatrics 127, 304–311 (2011).
Lee, H., Dichtl, S., Mormanova, Z., Dalla Pozza, R. & Genzel-Boroviczeny, O. In adolescence, extreme prematurity is associated with significant changes in the microvasculature, elevated blood pressure and increased carotid intima-media thickness. Arch. Dis. Child. 99, 907–911 (2014).
Shimizu, T. et al. Abdominal aortic intima-media thickness in preschool children born preterm. Pediatr. Cardiol. 35, 121–125 (2014).
Mohlkert, L. A. et al. The preterm heart in childhood: left ventricular structure, geometry, and function assessed by echocardiography in 6-year-old survivors of periviable births. J. Am. Heart Assoc. 7, e007742 (2018).
Lewandowski, A. J. The preterm heart: a unique cardiomyopathy? Pediatr. Res. 85, 738–739 (2019).
Bassareo, P. P. et al. Reduced brachial flow-mediated vasodilation in young adult ex extremely low birth weight preterm: a condition predictive of increased cardiovascular risk? J. Matern. Fetal Neonatal Med. 23 (Suppl. 3), 121–124 (2010).
Cheung, Y. F., Wong, K. Y., Lam, B. C. & Tsoi, N. S. Relation of arterial stiffness with gestational age and birth weight. Arch. Dis. Child. 89, 217–221 (2004).
Wei, F. F. et al. Retinal and renal microvasculature in relation to central hemodynamics in 11-year-old children born preterm or at term. J. Am. Heart Assoc. 9, e014305 (2020).
Melville, J. M. & Moss, T. J. The immune consequences of preterm birth. Front. Neurosci. 7, 79 (2013).
Markopoulou, P. et al. Increased circulating endothelial progenitor cells (EPCs) in prepubertal children born prematurely: a possible link between prematurity and cardiovascular risk. Pediatr. Res. https://doi.org/10.1038/s41390-020-01190-y (2020).
Bertagnolli, M. et al. Endothelial colony-forming cells in young adults born preterm: a novel link between neonatal complications and adult risks for cardiovascular disease. J. Am. Heart Assoc. 7, e009720 (2018).
Dignat-George, F. & Boulanger, C. M. The many faces of endothelial microparticles. Arterioscler. Thromb. Vasc. Biol. 31, 27–33 (2011).
Agouni, A. et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am. J. Pathol. 173, 1210–1219 (2008).
Tramontano, A. F. et al. Circulating endothelial microparticles in diabetes mellitus. Mediators Inflamm. 2010, 250476 (2010).
Bernal-Mizrachi, L. et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am. Heart J. 145, 962–970 (2003).
Fenton, T. R. & Kim, J. H. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 13, 59 (2013).
Higgins, R. D. et al. Bronchopulmonary dysplasia: executive summary of a workshop. J. Pediatr. 197, 300–308 (2018).
Cutfield, W. S., Jefferies, C. A., Jackson, W. E., Robinson, E. M. & Hofman, P. L. Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal children. Pediatr. Diabetes 4, 119–125 (2003).
Dalla Pozza, R. et al. Intima media thickness measurement in children: a statement from the Association for European Paediatric Cardiology (AEPC) Working Group on Cardiovascular Prevention endorsed by the Association for European Paediatric Cardiology. Atherosclerosis 238, 380–387 (2015).
Järvisalo, M. J. et al. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation 104, 2943–2947 (2001).
Thijssen, D. H. et al. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur. Heart J. 40, 2534–2547 (2019).
Lai, W. W. et al. Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 19, 1413–1430 (2006).
Amabile, N. et al. Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study. Eur. Heart J. 35, 2972–2979 (2014).
Bruyndonckx, L. et al. Endothelial progenitor cells and endothelial microparticles are independent predictors of endothelial function. J. Pediatr. 165, 300–305 (2014).
Deng, F., Wang, S. & Zhang, L. Endothelial microparticles act as novel diagnostic and therapeutic biomarkers of circulatory hypoxia-related diseases: a literature review. J. Cell Mol. Med. 21, 1698–1710 (2017).
Shebl, S. S. et al. Thrombo-hemorrhagic liability in children with congenital heart diseases. Hematol. Oncol. Stem Cell Ther. 11, 123–128 (2018).
Adly, A. A. et al. Vascular dysfunction in patients with young β-thalassemia: relation to cardiovascular complications and subclinical atherosclerosis. Clin. Appl Thromb. Hemost. 21, 733–744 (2015).
Ding, Y. Y. et al. Correlation between brachial artery flow-mediated dilation and endothelial microparticle levels for identifying endothelial dysfunction in children with Kawasaki disease. Pediatr. Res. 75, 453–458 (2014).
Dursun, I. et al. Circulating endothelial microparticles in children with Henoch-Schönlein purpura; preliminary results. Rheumatol. Int. 31, 1595–1600 (2011).
Narin, N. et al. Are endothelial microparticles early markers of pulmonary hypertension? Biomarkers 19, 319–325 (2014).
Boulanger, C. M. et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104, 2649–2652 (2001).
Edwards, M. O. et al. Higher systolic blood pressure with normal vascular function measurements in preterm-born children. Acta Paediatr. 103, 904–912 (2014).
Witte, D. R. et al. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? J. Am. Coll. Cardiol. 45, 1987–1993 (2005).
Seals, D. R., Jablonski, K. L. & Donato, A. J. Aging and vascular endothelial function in humans. Clin. Sci. (Lond.). 120, 357–375 (2011).
Wexler, O. et al. Brachial artery reactivity in patients with severe sepsis: an observational study. Crit. Care 16, R38 (2012).
Philpott, A. & Anderson, T. J. Reactive hyperemia and cardiovascular risk. Arterioscler Thromb. Vasc. Biol. 27, 2065–2067 (2007).
Lammi, M. R. et al. Microparticles in systemic sclerosis: potential pro-inflammatory mediators and pulmonary hypertension biomarkers. Respirology 24, 675–683 (2019).
Kosanovic, D. et al. Enhanced circulating levels of CD3 cells-derived extracellular vesicles in different forms of pulmonary hypertension. Pulm. Circ. 9, 2045894019864357 (2019).
Flint, A. C. et al. Effect of systolic and diastolic blood pressure on cardiovascular outcomes. N. Engl. J. Med. 381, 243–251 (2019).
Alexander, B. T., Dasinger, J. H. & Intapad, S. Fetal programming and cardiovascular pathology. Compr. Physiol. 5, 997–1025 (2015).
Skilton, M. R. et al. Fetal growth and preterm birth influence cardiovascular risk factors and arterial health in young adults: the Cardiovascular Risk in Young Finns Study. Arterioscler. Thromb. Vasc. Biol. 31, 2975–2981 (2011).
The authors are grateful towards all children and their parents participating voluntarily in the study.
The authors declare no competing interests
Informed written consent was obtained from parents and children.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Markopoulou, P., Papanikolaou, E., Loukopoulou, S. et al. Elevated circulating endothelial microparticles (EMPs) in prepubertal children born preterm. Pediatr Res (2021). https://doi.org/10.1038/s41390-021-01655-8